Biotech

All Articles

Basilea scores $268M BARDA financing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work cultivating brand new antifungals has actually received a considerable...

Capricor sells Europe liberties to late-stage DMD treatment for $35M

.Having already gathered up the USA rights to Capricor Therapies' late-stage Duchenne muscular dystr...

FDA scraps adcomm for Applied's rare health condition medication

.After dismissing the selection meeting for Applied Rehabs' metabolic problem medicine govorestat, t...

Novo inks $600M NanoVation bargain to analyze hereditary medicines ex-liver

.Novo Nordisk is continuing its own push into genetic medications, accepting pay NanoVation Rehabs a...

Innovent links cytokine to colon cancer cells responses

.Innovent Biologics has actually produced the instance that its checkpoint inhibitor-cytokine combin...

Merck, Daiichi ADC hits target in phase 3 lung cancer cells study

.A phase 3 test of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) h...

Rakovina strengthens AI concentrate along with collab to choose cancer cells aim ats

.Five months after Rakovina Therapies pivoted toward expert system, the cancer-focused biotech has j...

Ascendis' dwarfism medication hits in phase 3, endangers BioMarin

.Ascendis Pharma has emerged as a potential hazard to BioMarin's Voxzogo, reporting period 3 growth ...

Despite ph. 3 overlook, Alkeus views path ahead of time for eye disease property

.Though Alkeus Pharmaceuticals' dental eye disease resource fell short to considerably decrease geog...

Kairos goes social with $6M IPO to money trials of cancer cells medicine

.Along with a trio of biotechs reaching the Nasdaq on Friday, it was effortless to miss a smaller-sc...